Final Glance: Pharmaceuticals companies
AP - 53 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 103.28 (-0.51), BAX: 71.11 (-0.38), PFE: 31.42 (+0.26), BMY: 58.48 (-0.10)
Final Glance: Medical Devices companies
AP - 53 mins ago
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
ZMH: 115.80 (-0.99), JNJ: 103.28 (-0.51), MDT: 71.22 (-0.36), BAX: 71.11 (-0.38)
Pharmacyclics Reports Encouraging Data on Cancer Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 12 mins ago
Pharmacyclics, Inc. (PCYC) announced encouraging data on its oncology drug, Imbruvica.
AGN: 209.37 (-2.06), JNJ: 103.28 (-0.51), PCYC: 119.85 (-0.12), ABBV: 64.33 (-0.32)
AOL and Gilead Sciences are big market movers
AP - 27 mins ago
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
F: 14.62 (-0.14), K.TO: 3.95 (+0.47), CS: 23.81 (-0.43), BBEP: 6.90 (+0.08), SDRL: 10.48 (-0.33), NBG: 1.58 (-0.08), CYBX: 54.36 (-3.43), JNJ: 103.28 (-0.51), ISIS: 65.44 (-2.73), KGC: 3.33 (+0.38), AOL: 46.25 (+1.51), CVEO: 3.11 (-0.32), EBIX: 18.60 (+2.32), THLD: 3.55 (-0.13), CEMP: 23.15 (-1.40), VZ: 47.04 (+0.47), XOOM: 16.82 (-0.07)
Isis Pharmaceuticals Up on Collaboration with J&J - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 37 mins ago
Isis Pharmaceuticals (ISIS) inked a global collaboration with Johnson & Johnson's (JNJ) Janssen Biotech, Inc for the discovery and development of antisense drugs for treating autoimmune disorders of the gastrointestinal tract.
BIIB: 334.65 (-2.09), JNJ: 103.28 (-0.51), ISIS: 65.44 (-2.73), AZN: 68.16 (-1.70)
Johnson & Johnson begins Ebola vaccine testing in humans
AP - Tue Jan 06, 2:27PM CST
NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson has begun testing an Ebola vaccine in humans intended to counter a strain of the virus similar to the one that has wreaked havoc in West Africa.
JNJ: 103.28 (-0.51)
Selling Guidelines For Self Directed Investors
Chowder - at Seeking Alpha - Tue Jan 06, 2:13PM CST
HYH: 45.65 (+0.88), ABT: 44.40 (-0.51), FTR: 6.44 (-0.06), MDLZ: 35.99 (-0.25), DUK: 84.20 (+1.36), NUE: 46.46 (-0.68), ED: 66.08 (+0.37), KMB: 113.78 (-1.11), KRFT: 61.86 (+0.01), SDRL: 10.48 (-0.33), HCBK: 9.56 (-0.20), WM: 51.27 (+0.04), DRI: 58.19 (+0.20), JNJ: 103.28 (-0.51), CDK: 39.71 (-0.11), ADP: 82.54 (-0.69), LNCO: 11.31 (+0.09), TOO: 23.95 (-0.07), BP: 35.83 (-0.27), ABBV: 64.33 (-0.32), PG: 89.60 (-0.41), GIS: 52.02 (-0.13), CTL: 38.27 (-0.48)
Midday Glance: Pharmaceuticals companies
AP - Tue Jan 06, 12:17PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 103.28 (-0.51), BAX: 71.11 (-0.38), PFE: 31.42 (+0.26), BMY: 58.48 (-0.10)
Midday Glance: Medical Devices companies
AP - Tue Jan 06, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are down at 1 p.m.:
ZMH: 115.80 (-0.99), JNJ: 103.28 (-0.51), MDT: 71.22 (-0.36), BAX: 71.11 (-0.38)
Why Biogen Idec Inc. Stock Catapulted 10% Higher in December
Sean Williams, The Motley Fool - Motley Fool - Tue Jan 06, 10:31AM CST
What: Shares of Biogen Idec , a biotech juggernaut primarily focused on treating multiple sclerosis and autoimmune disorders, scorched higher by 10% in December, based on data from S&P Capital IQ , on the heels of positive clinical data...
JNJ: 103.28 (-0.51), BIIB: 334.65 (-2.09), PFE: 31.42 (+0.26), DB: 28.36 (-0.46), LLY: 69.72 (+0.35)
Stocks Turn Lower as 'Structural Flaws' in Global Economy Surface
at The Street - Tue Jan 06, 10:10AM CST
Stocks turn lower after Monday's broad selloff.
YHOO: 49.21 (+0.08), JNJ: 103.28 (-0.51), COH: 36.30 (-0.43), WBA: 74.69 (+0.19), AOL: 46.25 (+1.51), VZ: 47.04 (+0.47)
Early Glance: Pharmaceuticals companies
AP - Tue Jan 06, 9:37AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 10 a.m.:
JNJ: 103.28 (-0.51), BAX: 71.11 (-0.38), PFE: 31.42 (+0.26), BMY: 58.48 (-0.10)
Early Glance: Medical Devices companies
AP - Tue Jan 06, 9:37AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 115.80 (-0.99), JNJ: 103.28 (-0.51), MDT: 71.22 (-0.36), BAX: 71.11 (-0.38)
Watch for Shares of Johnson & Johnson (JNJ) to Approach Resistance at $105.12
Comtex SmarTrend(R) - Tue Jan 06, 9:31AM CST
Johnson & Johnson (NYSE:JNJ) has opened bullishly above the pivot of $104.07 today and has reached the first level of resistance at $104.45. Should the shares continue to rise, the resistance pivots of $105.12 and $106.16 will be of interest.
JNJ: 103.28 (-0.51)
Company News for January 06, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 9:10AM CST
Companies in the News are: KITE,AMGN,STI,ISIS,NPSP,GS
JNJ: 103.28 (-0.51), GS: 184.53 (-3.81), ISIS: 65.44 (-2.73), KITE: 71.45 (+1.70), NPSP: 41.05 (+2.92), STI: 39.08 (-1.16), AMGN: 152.90 (-5.09)
Johnson & Johnson Dividend Stock Analysis
Roadmap2Retire - at Seeking Alpha - Tue Jan 06, 8:19AM CST
JNJ: 103.28 (-0.51)
My Income Portfolio Quarterly Update (Q4 2014)
Invest Yourself - at Seeking Alpha - Tue Jan 06, 8:13AM CST
AMLP: 16.95 (-0.23), GE: 24.07 (-0.53), MAIN: 28.34 (-0.80), HSY: 103.32 (+0.34), WMT: 86.31 (+0.66), AWK: 53.25 (+0.14), O: 50.27 (+0.65), INTC: 35.28 (-0.67), PEP: 93.02 (-0.71), JNJ: 103.28 (-0.51), DE: 85.73 (-0.72), WY: 36.07 (-0.04), DD: 70.89 (-0.83), LTC: 45.00 (+0.44), CSCO: 27.05 (-0.01), NSC: 103.00 (-3.39), HYD: 31.10 (+0.07), WFC: 52.09 (-1.11), PGX: 14.73 (+0.01), SO: 49.75 (+0.59), WM: 51.27 (+0.04), DRI: 58.19 (+0.20), ADM: 49.23 (-0.99), CVX: 108.03 (-0.05), AFL: 58.95 (-0.53)
Stock Futures Slip Into Red as Crude Oil Rout Continues
at The Street - Tue Jan 06, 7:58AM CST
Stock futures turn lower on Tuesday, triggered by a selloff of crude oil.
YHOO: 49.21 (+0.08), JNJ: 103.28 (-0.51), AOL: 46.25 (+1.51), AAL: 53.04 (-0.84), JBLU: 14.97 (-0.25), VZ: 47.04 (+0.47), LUV: 40.46 (-1.18)
Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen
PR Newswire Europe - Tue Jan 06, 6:51AM CST
- Company Has Produced More Than 400,000 Vaccine Regimens for Use in Large-Scale Clinical Trials by April 2015
JNJ: 103.28 (-0.51)
J&J begins Ebola vaccine trial in U.K.
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 3:07AM CST
JNJ: 103.28 (-0.51)